Ipamorelin
IPIpamorelin is a pentapeptide growth hormone secretagogue and selective ghrelin-receptor (GHS-R1a) agonist, first described in the late 1990s. It is used as a reference compound in receptor-selectivity and secretagogue research and is supplied as a lyophilised powder for in-vitro research only.
- CAS
- 170851-70-4
- Purity
- ≥99%
- Form
- Lyophilised powder
- Price
- On enquiry
Research contexts
- GHS-R1a receptor binding and selectivity assays
- Comparative secretagogue studies alongside GHRP-2 and GHRP-6
- Pituitary cell-culture signalling models
Listed for reference only. Nothing here describes, suggests or implies any use in humans or animals.
Handling and storage
Store lyophilised at -20 °C, protected from light and moisture. Reconstituted material should be kept at 2-8 °C and used within a short window.
Testing and documentation
Batch 2025-12 was analysed by Janoshik Analytical on 30 December 2025 at 99.504% purity. Report #95851 can be verified independently with key XKEJDN6SK5RV.
Common questions
What is the CAS number for Ipamorelin?
Ipamorelin is listed under CAS 170851-70-4.
Related compounds
Research use only. Supplied strictly for in-vitro laboratory research by qualified researchers. Not a therapeutic good, not for human or veterinary use, not for diagnostic purposes, and not for food or cosmetic manufacture. No claims of safety or efficacy are made or implied.